We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Novel Approach Uses Genetic Data To Reduce Drug Development Failures

News   Sep 08, 2020 | Original story from the University of Bristol

 
Novel Approach Uses Genetic Data To Reduce Drug Development Failures

Comparing the genetic inferred causal relationships of proteins on human diseases with historic drug development programs, this study, for the first time, showed that protein-disease pairs with genetic predicted causal evidence is more likely to be approved drugs for the same indications. Credit: Dr Jie Zheng.

 
 
Advertisement
 

RELATED ARTICLES

Anti-Alzheimer's Gene Variant Enhances Immune Cells

News

A new study conducted by researchers at the University of Eastern Finland found that a genetic variant named PLCG2-P522R, which protects against Alzheimer's disease, enhances several key functions of immune cells.

READ MORE

Is DINCH a Good Alternative to Phalates?

News

Phthalates, found in detergents, shampoos, soaps and other everyday items, can disrupt our endocrine system and so have been replaced by alternatives in many products. Researchers look at the impact of these alternatives on pregnant women.

READ MORE

New Drug Could Offer Hope for Muscular Dystrophy Patients

News

A new drug offers hope for young boys with the progressive neuromuscular disease Duchenne muscular dystrophy (DMD) by potentially offering an alternative to high-dose glucocorticoids that have significant side effects.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE